Recent advances in osteoarthritis research: A review of treatment strategies, mechanistic insights, and acupuncture

Osteoarthritis is one of the most common joint conditions in the world, affecting approximately 350 million people globally. It is a chronic disease characterized by gradual deterioration of joint cartilage, leading to pain, stiffness, and functional limitation that significantly impact patients' quality of life. The number of cases increased dramatically by 113.25% between 1990 and 2019, transforming osteoarthritis into a growing global health threat. This growth is directly related to population aging and increasing obesity, creating an ever-greater challenge for healthcare systems worldwide.

The projection for 2040 suggests a 49% increase in diagnosed cases in the United States alone, highlighting the urgency of developing more effective treatments.

This study aimed to review the most recent advances in osteoarthritis research, analyzing traditional and innovative treatment strategies, as well as the molecular mechanisms involved in the development of the disease. The researchers conducted a comprehensive narrative review of the scientific literature, examining everything from conventional treatments to emerging therapies. The methodology included analysis of clinical studies, experimental research, and epidemiological data to better understand the risk factors, pathological mechanisms, and therapeutic options available. Several factors influencing the development of osteoarthritis were analyzed, including joint shape, age, obesity, sex, and ethnicity, as well as the complex molecular mechanisms underlying disease progression.

The results revealed that osteoarthritis is a multifactorial disease with six main mechanisms: articular cartilage degeneration, subchondral bone changes, synovial inflammation, oxidative stress, protease activity, and epigenetic modifications. Research demonstrated that women are more affected than men, especially after menopause, and that there are significant ethnic disparities in disease incidence and progression. Regarding treatments, nonsteroidal anti-inflammatory drugs and acetaminophen remain the main pharmacological options for controlling pain and inflammation. Joint replacement surgery remains the alternative when conservative treatments fail.

Surprisingly, acupuncture emerged as a promising therapeutic option, demonstrating efficacy in reducing pain and inflammation through mechanisms that include the release of natural analgesics such as endorphins, modulation of the immune system, and inhibition of inflammatory factors such as IL-1β and TNF-α.

The clinical implications of these findings are considerable for patients and healthcare professionals. For patients, this means there is a growing range of therapeutic options that can be combined for more effective and personalized treatment. Acupuncture, in particular, offers a safe and economically viable alternative to traditional medications, especially important for patients who do not tolerate anti-inflammatories well. For professionals, the results emphasize the importance of a multidisciplinary approach in the treatment of osteoarthritis, considering not only symptomatic control but also strategies that may modify the course of the disease.

The development of disease-modifying osteoarthritis drugs represents an urgent need and an opportunity to fundamentally transform the management of this debilitating condition.

The study presents important limitations that must be considered. Although emerging therapies such as molecularly targeted drugs, biologic treatments, and regenerative medicine show potential, they still face significant challenges in terms of long-term efficacy and safety. Clinical studies have shown limited joint protection, especially in diverse patient populations. Epigenetic therapies, although promising, still face technical challenges related to delivery efficiency and unintended side effects.

Future research should prioritize the development of combination treatments that maximize synergistic effects and improve long-term outcomes. It is essential to continue investigating the molecular mechanisms driving osteoarthritis, using multi-omics approaches to identify new therapeutic targets. The development of personalized treatment plans based on molecular profiles represents a promising direction, as does interdisciplinary and international collaboration to accelerate innovation in this vital field of medicine.